Hoth Therapeutics Inc (HOTH)

Official site

BIOTECHNOLOGY

$0.53

-0.04 (-6.73%)

Last updated: Oct 14, 2026 at 5:00 PM ET

Earnings

Performance (10Y)

Beat Rate

50%(14/28)

Avg Surprise

-9.59%

Upcoming Estimates

Period ending Jun 30, 2026

EPS Consensus$N/A

Revenue Consensus

Range$0 - $0

0 analysts

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Jun 30, 2026Jun 26EST	-	N/A	-	-	-	-	-	-
Dec 31, 2025Dec 25 Reported Mar 27, 2026Reported Mar 27	$-0.16	$-0.10	$-0.10 - $-0.10	-60.00%	Miss	1	1 0 30d	+50.0%
Sep 30, 2025Sep 25 Reported Nov 12, 2025Reported Nov 12	$-0.30	$-0.27	$-0.27 - $-0.27	-11.11%	Miss	1	1 0 30d	+3.2%
Jun 30, 2025Jun 25 Reported Aug 12, 2025Reported Aug 12	$-0.17	$-0.31	$-0.31 - $-0.31	+45.16%	Beat	0	No revisions (30d)	+29.2%
Mar 31, 2025Mar 25 Reported May 12, 2025Reported May 12	$-0.27	$-0.34	$-0.34 - $-0.34	+20.59%	Beat	1	0 1 30d	+41.3%
Dec 31, 2024Dec 24 Reported Mar 28, 2025Reported Mar 28	$-0.32	$-0.43	$-0.47 - $-0.39	+25.58%	Beat	2	No revisions (30d)	+0.0%
Sep 30, 2024Sep 24 Reported Nov 12, 2024Reported Nov 12	$-0.31	$-0.34	$-0.37 - $-0.30	+8.82%	Beat	3	No revisions (30d)	+48.3%
Jun 30, 2024Jun 24 Reported Aug 9, 2024Reported Aug 9	$-0.24	$-0.43	$-0.47 - $-0.39	+44.19%	Beat	2	1 0 30d	+57.7%
Mar 31, 2024Mar 24 Reported May 14, 2024Reported May 14	$-0.46	$-0.43	$-0.43 - $-0.43	-6.98%	Miss	1	No revisions (30d)	+83.9%
Dec 31, 2023Dec 23 Reported Mar 28, 2024Reported Mar 28	$-0.32	$-0.51	$-0.53 - $-0.49	+37.25%	Beat	2	No revisions (30d)	+88.8%
Sep 30, 2023Sep 23 Reported Nov 13, 2023Reported Nov 13	$-0.60	$-0.72	$-0.88 - $-0.57	+16.67%	Beat	2	No revisions (30d)	+70.7%
Jun 30, 2023Jun 23 Reported Aug 11, 2023Reported Aug 11	$-0.57	N/A	-	+51.10%	Beat	1	No revisions (30d)	+74.8%
Mar 31, 2023Mar 23 Reported May 15, 2023Reported May 15	$-2.86	$-2.29	$-2.34 - $-2.25	-24.89%	Miss	2	No revisions (30d)	-4.0%
Dec 31, 2022Dec 22 Reported Mar 31, 2023Reported Mar 31	$-2.86	$-2.29	$-2.67 - $-1.91	-24.89%	Miss	2	No revisions (30d)	+18.3%
Sep 30, 2022Sep 22 Reported Nov 10, 2022Reported Nov 10	$-2.05	$-2.39	$-2.43 - $-2.36	+14.23%	Beat	2	1 1 30d	+41.4%
Jun 30, 2022Jun 22 Reported Aug 12, 2022Reported Aug 12	$-2.25	$-2.37	$-2.38 - $-2.37	+5.06%	Beat	2	No revisions (30d)	+35.7%
Mar 31, 2022Mar 22 Reported May 12, 2022Reported May 12	$-2.75	$-3.50	$-3.50 - $-3.50	+21.43%	Beat	1	No revisions (30d)	+54.2%
Dec 31, 2021Dec 21 Reported Mar 30, 2022Reported Mar 30	$-3.50	$-3.12	$-3.13 - $-3.12	-12.18%	Miss	2	No revisions (30d)	-250.0%
Sep 30, 2021Sep 21 Reported Nov 10, 2021Reported Nov 10	$-3.50	$-3.37	$-3.39 - $-3.36	-3.86%	Miss	2	2 0 30d	+12.5%
Jun 30, 2021Jun 21 Reported Aug 11, 2021Reported Aug 11	$-3.50	$-4.25	$-4.26 - $-4.24	+17.65%	Beat	2	No revisions (30d)	+30.0%
Mar 31, 2021Mar 21 Reported May 13, 2021Reported May 13	$-6.00	$-2.50	$-2.50 - $-2.50	-140.00%	Miss	2	No revisions (30d)	-33.3%
Dec 31, 2020Dec 20 Reported Mar 16, 2021Reported Mar 16	$-1.00	N/A	-	+60.00%	Beat	1	No revisions (30d)	+90.5%
Sep 30, 2020Sep 20 Reported Nov 10, 2020Reported Nov 10	$-4.00	$-3.37	$-3.41 - $-3.34	-18.69%	Miss	2	No revisions (30d)	+5.9%
Jun 30, 2020Jun 20 Reported Aug 13, 2020Reported Aug 13	$-5.00	$-3.75	$-3.78 - $-3.73	-33.33%	Miss	3	No revisions (30d)	-53.8%
Mar 31, 2020Mar 20 Reported May 13, 2020Reported May 13	$-4.50	$-4.17	$-4.19 - $-4.14	-7.91%	Miss	3	1 0 30d	-3990.9%
Dec 31, 2019Dec 19 Reported Mar 2, 2020Reported Mar 2	$-10.50	$-3.42	$-3.44 - $-3.38	-207.02%	Miss	3	No revisions (30d)	-34900.0%
Sep 30, 2019Sep 19 Reported Nov 12, 2019Reported Nov 12	$-4.25	$-2.42	$-2.45 - $-2.38	-75.62%	Miss	3	No revisions (30d)	-
Jun 30, 2019Jun 19 Reported Aug 14, 2019Reported Aug 14	$-3.25	$-2.75	$-2.75 - $-2.75	-18.18%	Miss	1	No revisions (30d)	-
Mar 31, 2019Mar 19 Reported Apr 1, 2019Reported Apr 1	$-0.11	$-0.12	-	+8.33%	Beat	-	-	-
Dec 31, 2018Dec 18 Reported Feb 11, 2019Reported Feb 11	$-0.03	N/A	-	N/A	Beat	-	-	-

Key Metrics

Valuation
P/E Ratio	N/A	EV/EBITDA	N/A
Price/FCF	-0.84x	FCF Yield	-119.73%
Profitability
Profit Margin	N/A	Operating Margin	N/A
ROE	N/A	ROIC	N/A
Financial Health
Debt/Equity	0.00x	Interest Coverage	N/A
Current Ratio	3.39x	Quick Ratio	3.39x
Trading Statistics
Beta	N/A	Avg Volume	459.82K
52-Week High	N/A	52-Week Low	N/A

Technical Indicators Dashboard

Moving Averages

SMA 10$0.65

SMA 20$0.70

SMA 50$0.72

SMA 200$0.88

EMA 10$0.63

EMA 20$0.67

EMA 50$0.73

EMA 200$0.88

MACD

Line: -0.04Signal: -0.02Hist: -0.02

ADX

ADX: 20.6+DI: 15.6-DI: 32.5

Aroon & PSAR

Aroon Up20.0

Aroon Down100.0

PSAR$0.77

Bollinger Bands

Upper Band$0.85

Lower Band$0.56

%B Position4134%(Upper)

Band Width-0.08

RSI (14-Day)

Oversold

26.9

Momentum Oscillators

Stoch %K2.2

Stoch %D4.1

Williams %R-99.1

ROC (10d)-25.5%

Momentum-0.18

CCI (20d)-198.8

MFI (14d)41.6

Volatility Measures

ATR (14d)$0.05(9.8%)

StdDev (20d)0.07

Hist Vol61.7%(High)

Volume Flow

VWAP$0.54

OBV459.4M

AD Line-124.6M

CMF (20d)-0.456

Volume Metrics

Avg Vol (20d)345.7K

Vol Ratio0.9x

VWMA (20d)$0.71

Pivot Points

R3$0.65

R2$0.63

R1$0.60

Pivot Point$0.58

S1$0.55

S2$0.53

S3$0.51

Advanced Oscillators

TSI-23.34

Ultimate Osc21.1

KST-94.16

Financial Data

Quarter	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023
Total Revenue	$0	$0	$0	$0	$0	$0	$0	$0	$0	$59,538	$0	$0
Cost of Revenue	N/A	N/A	N/A	N/A	$4,354	N/A	N/A	N/A	N/A	$29,769	$6,752	$7,897
Gross Profit	N/A	N/A	N/A	N/A	$-4,354	N/A	N/A	N/A	N/A	$29,769	$-6,752	$-7,897

Operating Expenses	$2.65M	$2.61M	$4.08M	$2.20M	$3.48M	$2.38M	$2.13M	$1.65M	$2.16M	$1.70M	$2.09M	$1.71M
R&D	$1.52M	$1.31M	$1.63M	$1.04M	$1.96M	$1.32M	$897,510	$566,335	$571,642	$914,599	$974,374	$652,202
SG&A	$1.13M	$1.29M	$2.45M	$1.16M	$1.50M	$1.05M	$1.23M	$1.08M	$1.57M	$783,217	$1.11M	$1.05M
Operating Income	$-2,648,449	$-2,605,019	$-4,080,663	$-2,199,649	$-3,476,017	$-2,383,182	$-2,132,253	$-1,645,839	$-2,159,904	$-1,697,816	$-2,092,980	$-1,708,629

Interest Income	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Interest Expense	$44,016	$83,170	$25,137	$0	$0	$0	$0	$0	$0	$9,310	$0	$164,402
Income Before Tax	$-2,692,465	$-2,688,189	$-4,105,800	$-2,199,476	$-3,475,836	$-2,382,990	$-2,132,053	$-1,632,474	$-2,146,529	$-1,702,269	$-2,086,583	$-1,873,031
Income Tax Expense	$0	$0	$0	$0	$0	$0	$0	$-1,645,839	$-2,054,159	$-1,697	$33,975	$42,317

Net Income	$-2,692,465	$-2,688,189	$-4,105,800	$-2,199,476	$-3,475,836	$-2,382,990	$-2,132,053	$-1,632,474	$-2,146,529	$-1,702,269	$-2,086,583	$-1,873,031

EBITDA	$-2,648,449	$-2,605,019	$-4,105,800	$-2,199,479	$-3,476,017	$-2,383,182	$-2,132,253	$-1,645,839	$-2,054,160	$-1,702,273	$-2,092,980	$-1,544,227
EBIT	N/A	N/A	N/A	N/A	$-3,480,371	N/A	N/A	$-3,291,679	$-4,108,318	$-3,395,632	$-4,185,960	$-3,252,856

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about HOTH

News

HOTH stock trades on its latest clinical and financial update.

Hoth Therapeutics, Inc. (HOTH) stock is being traded based on its recent clinical and financial update, according to an AD HOC NEWS report. As a micro-cap company...

Ad-hoc-news.de•Jul 21, 2026 9:36 AM ET7/21/26•Neutral

HOTH Valuation and Fair Value

P/FCF: -0.8x
P/B: 2.0x

See GNG's fair value

HOTH Profitability: Margins, ROIC and FCF

FCF yield: -119.7%

HOTH Competitors

Company	Ticker
American Shared Hospital Service	AMS
Jaguar Animal Health Inc	JAGX
Immuron Ltd ADR	IMRN
Exicure Inc	XCUR
Moleculin Biotech Inc	MBRX
OSR Holdings Inc	OSRH
MetaVia Inc.	MTVA
CNS Pharmaceuticals Inc	CNSP

Sector: Healthcare

HOTH Earnings: Beat Rate and Next Report

Beat rate: 5 of 8 quarters (62.5%)
Average surprise: 8.3%

Frequently Asked Questions About HOTH

Does HOTH pay dividends?

Hoth Therapeutics Inc (HOTH) does not currently pay a regular dividend.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In